Kelly Karl

Kelly Karl

Auto-generated profile, based on publicly available information

Kelly Karl

Department of Materials Science and Engineering, Institute for NanoBioTechnology, and Program in Molecular Biophysics, Johns Hopkins University

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
KKKelly Karl
Kelly Karl
MPMichael D. Paul
Michael D. Paul
EPElena Pasquale
Elena Pasquale
KHKalina Hristova
Kalina Hristova
Ligand bias is the ability of ligands to differentially activate certain receptor signaling responses compared with others. It reflects differences in the responses of a receptor to specific ligands and has implications for the development of highly specific therapeutics. Whereas ligand bias has been studied primarily for G protein–coupled receptors (GPCRs), there are also reports of ligand bias for receptor tyrosine kinases (RTKs). However, the understanding of RTK ligand bias is lagging behind the knowledge of GPCR ligand bias. In this review, we highlight how protocols that were developed to study GPCR signaling can be used to identify and quantify RTK ligand bias. We also introduce an operational model that can provide insights into the biophysical basis of RTK activation and ligand bias. Finally, we discuss possible mechanisms underpinning RTK ligand bias. Thus, this review serves as a primer for researchers interested in investigating ligand bias in RTK signaling.

1 December 2021 in Current Opinion in Structural Biology
Verified
Journal Article
Closed access
KKKelly Karl
Kelly Karl
KHKalina Hristova
Kalina Hristova

1 July 2021 in Journal of Biological Chemistry
Verified
Journal Article
Open access
TLTaylor P. Light
Taylor P. Light
MGMaricel Gomez-Soler
Maricel Gomez-Soler
ZWZichen Wang
Zichen Wang
KKKelly Karl
Kelly Karl
EZElmer Zapata-Mercado
Elmer Zapata-Mercado
EPElena Pasquale
Elena Pasquale
The Eph receptor tyrosine kinases and their ephrin ligands regulate many physiological and pathological processes. EphA4 plays important roles in nervous system development and adult homeostasis, while aberrant EphA4 signaling has been implicated in neurodegeneration. EphA4 may also affect cancer malignancy, but the regulation and effects of EphA4 signaling in cancer are poorly understood. A correlation between decreased patient survival and high EphA4 mRNA expression in melanoma tumors that also highly express ephrinA ligands suggests that enhanced EphA4 signaling may contribute to melanoma progression. A search for EphA4 gain-of-function mutations in melanoma uncovered a mutation of the highly conserved leucine 920 in the EphA4 sterile alpha motif (SAM) domain. We found that mutation of L920 to phenylalanine (L920F) potentiates EphA4 autophosphorylation and signaling, making it the first documented EphA4 cancer mutation that increases kinase activity. Quantitative Föster resonance energy transfer and fluorescence intensity fluctuation (FIF) analyses revealed that the L920F mutation induces a switch in EphA4 oligomer size, from a dimer to a trimer. We propose this switch in oligomer size as a novel mechanism underlying EphA4-linked tumorigenesis. Molecular dynamics simulations suggest that the L920F mutation alters EphA4 SAM domain conformation, leading to the formation of EphA4 trimers that assemble through two aberrant SAM domain interfaces. Accordingly, EphA4 wild-type and the L920F mutant are affected differently by the SAM domain and are differentially regulated by ephrin ligand stimulation. The increased EphA4 activation induced by the L920F mutation, through the novel mechanism we uncovered, supports a functional role for EphA4 in promoting pathogenesis.

1 January 1992 in Cold Spring Harbor Symposia on Quantitative Biology
Verified
Journal Article
Open access
PDF file
TOT.J. O'Dell
T.J. O'Dell
SGSeth G.N. Grant
Seth G.N. Grant
KKK. Karl
K. Karl
PSP.M. Soriano
P.M. Soriano
EKE.R. Kandel
E.R. Kandel
Detailed reviews describing work presented at the annual Cold Spring Harbor Symposia on Quantitative Biology

16 October 2023 in eLife preprints
Verified
Preprint
Open access
KKKelly Karl
Kelly Karl
NPNuala Del Piccolo
Nuala Del Piccolo
TLTaylor Light
Taylor Light
TRTanaya Roy
Tanaya Roy
PDPooja Dudeja
Pooja Dudeja
KHKalina Hristova
Kalina Hristova
The mechanism of differential signaling of multiple FGF ligands through a single FGF receptor is poorly understood. Here, we use biophysical tools to quantify multiple aspects of FGFR1 signaling in response to FGF4, FGF8 and FGF9: potency, efficacy, bias, ligand-induced oligomerization and downregulation, and conformation of the active FGFR1 dimers. We find that the three ligands exhibit distinctly different potencies and efficacies for inducing responses in cells. We further discover qualitative differences in the actions of the three FGFs through FGFR1, as FGF8 preferentially activates some of the probed downstream responses (FRS2 phosphorylation and extracellular matrix loss), while FGF4 and FGF9 preferentially activate different probed responses (FGFR1 phosphorylation and cell growth arrest). Thus, FGF8 is a biased ligand, when compared to FGF4 and FGF9. Förster resonance energy transfer experiments reveal a correlation between biased signaling and the conformation of the FGFR1 transmembrane domain dimer. Our findings expand the mechanistic understanding of FGF signaling during development and bring the poorly understood concept of receptor tyrosine kinase ligand bias into the spotlight.

6 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
KKKelly Karl
Kelly Karl
NPNuala Del Piccolo
Nuala Del Piccolo
TLTaylor Light
Taylor Light
TRTanaya Roy
Tanaya Roy
PDPooja Dudeja
Pooja Dudeja
KHKalina Hristova
Kalina Hristova
The mechanism of differential signaling of multiple FGF ligands through a single FGF receptor is poorly understood. Here, we use biophysical tools to quantify multiple aspects of FGFR1 signaling in response to FGF4, FGF8 and FGF9: potency, efficacy, bias, ligand-induced oligomerization and downregulation, and conformation of the active FGFR1 dimers. We find that the three ligands exhibit distinctly different potencies and efficacies for inducing responses in cells. We further discover qualitative differences in the actions of the three FGFs through FGFR1, as FGF8 preferentially activates some of the probed downstream responses (FRS2 phosphorylation and extracellular matrix loss), while FGF4 and FGF9 preferentially activate different probed responses (FGFR1 phosphorylation and cell growth arrest). Thus, FGF8 is a biased ligand, when compared to FGF4 and FGF9. Förster resonance energy transfer experiments reveal a correlation between biased signaling and the conformation of the FGFR1 transmembrane domain dimer. Our findings expand the mechanistic understanding of FGF signaling during development and bring the poorly understood concept of receptor tyrosine kinase ligand bias into the spotlight.